ANI Pharmaceuticals (ANIP)

[Jp2011]

I thought this earnings season would actually break the norm and the stock would go higher, possibly even trading mid - 70's before earnings. Looks like that is not the case and it's just a typical case of ANI.

Even though this stock has performed better than most of its peers it still cannot get over the hump. Hopefully I am proven completely wrong on Tuesday but highly doubt it.


What kills me is how institutions (I am guessing) seem to have such great insight to earnings prior to release. I really think this needs investigated.



I believe if ANI disappoints on earnings shame on them. They rarely beat the earns they set out, usually always falling sort. I remember the last earnings call Art mentioned they had a "chemistry" question from the FDA regarding Corti. Hopefully bad news on Corti is not the reason for the fall in price. Also, where are the product launches????? The past two years they have failed to launch many products. Also, why no mention of revised guidance??


Just frustrated...….. watching paint dry seems to yield faster results. I just hope we are not getting screwed.